0001237899-12-000025.txt : 20120215 0001237899-12-000025.hdr.sgml : 20120215 20120215165304 ACCESSION NUMBER: 0001237899-12-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120214 FILED AS OF DATE: 20120215 DATE AS OF CHANGE: 20120215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 12616569 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-02-14 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2012-02-14 4 M 0 5000 33.42 A 5000 D Common Stock 2012-02-14 4 S 0 5000 110.02 D 0 D Common Stock 2012-02-14 4 M 0 10000 24.41 A 10000 D Common Stock 2012-02-14 4 S 0 10000 110.02 D 0 D Non-Qualified Stock Option (right to buy) 24.41 2012-02-14 4 M 0 10000 D 2020-01-04 Common Stock 10000 5000 D Non-Qualified Stock Option (right to buy) 33.42 2012-02-14 4 M 0 5000 D 2021-01-03 Common Stock 5000 10000 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 5,000 shares of Company stock on February 14, 2012 at prices ranging from $110.00 to $110.33.. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price. Represents volume-weighted average price of sales of 10,000 shares of Company stock on February 14, 2012 at prices ranging from $110.00 to $110.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 14, 2012 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Joseph L. Goldstein 2012-02-15